Search results for " brain"

showing 10 items of 985 documents

A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community

2011

Objectives We sought to define the cardiometabolic phenotype associated with rs5068, a genetic variant of the atrial natriuretic peptide (ANP) gene. Background The ANP and B-type natriuretic peptide play an important role in cardiorenal homeostasis but also exert metabolic actions. Methods We genotyped 1,608 randomly selected residents from Olmsted County, Minnesota. Subjects were well-characterized. Results Genotype frequencies were: AA 89.9%, AG 9.7%, and GG 0.4%; all subsequent analyses were AA versus AG+GG. The G allele was associated with increased plasma levels of N-terminal pro-atrial natriuretic peptide (p = 0.002), after adjustment for age and sex. The minor allele was also associa…

Malemedicine.medical_specialtyLinkage disequilibriumSettore MED/09 - Medicina InternaGenotypemedicine.drug_classPopulationBlood PressureArticlemetabolic syndromeBody Mass IndexRandom AllocationAtrial natriuretic peptideInternal medicineatrial natriuretic peptidelipid metabolismNatriuretic Peptide BrainHomeostasimedicineNatriuretic peptideHomeostasisHumansAlleleeducationAllelesAgedAlleleeducation.field_of_studycardiometabolic diseasebusiness.industryGenetic VariationDNAMiddle Agedmedicine.diseaseEchocardiography DopplerGenotype frequencyProtein Structure TertiaryMinor allele frequencyEndocrinologyPhenotypeFemaleMetabolic syndromebusinessCardiology and Cardiovascular Medicinenatriuretic peptidesAtrial Natriuretic FactorHuman
researchProduct

Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute hea…

2017

Aim: Baseline values of N-terminal pro B-type natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) predict all-cause mortality in acute heart failure (AHF). However, there is limited information about the added prognostic benefit of using longitudinal values, and how this predictive ability is modified when modelling together. The aim of this study was to determine the mutually-adjusted association between the longitudinal trajectories of NT-proBNP and CA125 with all-cause mortality after an episode of AHF. Methods and results: We included 946 consecutive patients discharged for AHF. NT-proBNP and CA125 were measured at each physician-patient encounter (median (interquartile…

Malemedicine.medical_specialtyLongitudinal studyTime Factorsacute heart failuremedicine.drug_class030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineRisk Assessment03 medical and health sciences0302 clinical medicineInterquartile rangeRisk FactorsInternal medicineCause of DeathNatriuretic Peptide BrainmedicineNatriuretic peptideHumans030212 general & internal medicineMortalitycarbohydrate antigen 125Survival rateCause of deathAgedRetrospective StudiesHeart Failurebusiness.industrylongitudinal studyMembrane ProteinsRetrospective cohort studyGeneral MedicineBrain natriuretic peptidemedicine.diseasePrognosisPeptide FragmentsSurvival RateEndocrinologyB-type natriuretic peptideSpainHeart failureCA-125 AntigenAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesEuropean heart journal. Acute cardiovascular care
researchProduct

Doxycycline reduces nitric oxide production in guinea pig inner ears.

2011

Abstract Objective Gentamicin application is an important therapeutic option to control vertigo spells in Meniere's disease. However, even in the case of low-dose intratympanic application, gentamicin might contribute to a pathological NO-increase leading to cochlear damage and hearing impairment. The study was performed to evaluate the nitric oxide (NO) reducing capacity of doxycycline in the inner ear after NO-induction by gentamicin. Methods In a prospective animal study, a single dose of gentamicin (10 mg/kg body weight) was injected intratympanically into male guinea pigs (n = 48). The auditory brainstem responses (ABRs) were recorded prior to application and 3, 5 and 7 days afterwards…

Malemedicine.medical_specialtyLuminescenceArginineGuinea PigsPharmacologyOrgan cultureNitric OxideNitric oxideGuinea pigchemistry.chemical_compoundOrgan Culture Techniquesotorhinolaryngologic diseasesmedicineEvoked Potentials Auditory Brain StemAnimalsProspective StudiesOrgan of CortiCochleaDoxycyclineomega-N-Methylargininebusiness.industryGeneral MedicineImmunohistochemistrySurgeryUp-Regulationmedicine.anatomical_structureNG-Nitroarginine Methyl EsterOtorhinolaryngologychemistryOrgan of CortiCytoprotectionDoxycyclineEar InnerSurgeryGentamicinGentamicinsbusinessmedicine.drugAuris, nasus, larynx
researchProduct

Prognostic Value of Brain Natriuretic Peptide in Acute Heart Failure: Mortality and Hospital Readmission

2008

The prognostic value of brain natriuretic peptide (BNP) measurement in patients with acute heart failure is not well understood. The aim of this study was to investigate the relationship between the BNP level and mortality and readmission for acute heart failure. We studied 569 consecutive patients who were admitted with a diagnosis of acute heart failure. The BNP level was measured after the patient became clinically stable. The relationship between the BNP level and mortality was assessed by Cox regression analysis, and the relationship with readmission, by competing risks regression analysis. During a median follow-up period of 9 (range, 3-18) months, 156 deaths (27.4%) and 140 readmissi…

Malemedicine.medical_specialtyMultivariate analysismedicine.drug_classPatient ReadmissionInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumansIn patientProspective Studiescardiovascular diseasesProspective cohort studyHeart FailureHospital readmissionProportional hazards modelbusiness.industryGeneral MedicineMiddle AgedPrognosisBrain natriuretic peptidemedicine.diseaseHeart failureAcute DiseaseCardiologyFemalebusinesshuman activitieshormones hormone substitutes and hormone antagonistsRevista Española de Cardiología (English Edition)
researchProduct

CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.

2019

In acute heart failure (AHF) with right ventricular dysfunction, the roles of amino-terminal pro-brain natriuretic peptide (NT-proBNP) and carbohydrate antigen 125 (CA125) are poorly understood, and functional tricuspid regurgitation (TR) severity is thought to indicate a poor prognosis. We examined the prognostic abilities of NT-proBNP and CA125 according to TR status among patients with AHF.TR severity was assessed during index hospitalization (108 ± 24 h after admission) and classified as none/trivial, mild, moderate, or severe. Multivariable Cox regression analysis was performed to assess how pre-discharge CA125 and NT-proBNP were associated with long-term all-cause mortality relative t…

Malemedicine.medical_specialtyMultivariate analysismedicine.drug_classRegurgitation (circulation)030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseases030212 general & internal medicineAgedAged 80 and overHeart FailureEjection fractionProportional hazards modelbusiness.industryMembrane ProteinsStroke VolumeMiddle Agedmedicine.diseasePrognosisPeptide FragmentsTricuspid Valve InsufficiencyHeart failureCA-125 AntigenCardiologyBiomarker (medicine)FemaleCardiology and Cardiovascular MedicineIndex hospitalizationbusinessBiomarkersInternational journal of cardiology
researchProduct

Comparison of N-terminal proB-type natriuretic peptide levels at different stages of visceral leishmaniosis and in patients with chronic kidney disea…

2018

N-terminal proB-type natriuretic peptide (NT-proBNP) may be a useful marker in canine leishmaniosis (CanL). The aim was to compare NT-proBNP in dogs at different LeishVet stages of CanL and with idiopathic chronic kidney disease (CKD). Dogs diagnosed with CanL or CKD and a group of healthy dogs were included (group A, five normal dogs; group B, six dogs LeishVet 1-2; group C, 13 dogs LeishVet 3-4; group D, six dogs with CKD). NT-proBNP was higher (P0.001) in group C (7.616 pmol/l, interquartile range (IQR) 3537-10,000 pmol/l) than in group A (293 pmol/l, IQR 257-373), group B (388.5 pmol/l, IQR 324-793) and group D (740 pmol/l, IQR 557-962 pmol/l). International Renal Interest Society (IRIS…

Malemedicine.medical_specialtyMyocarditisN-Terminal ProB-type Natriuretic Peptide040301 veterinary sciencesmedicine.drug_classLeft ventricular hypertrophyGastroenterologyGroup A0403 veterinary scienceDogsInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideAnimalsHumansIn patientcardiovascular diseasesDog DiseasesRenal Insufficiency ChronicGeneral Veterinarybusiness.industry0402 animal and dairy science04 agricultural and veterinary sciencesGeneral Medicinemedicine.disease040201 dairy & animal sciencePeptide FragmentsLeishmaniasis VisceralFemalebusinesshormones hormone substitutes and hormone antagonistsBiomarkersKidney diseaseThe Veterinary record
researchProduct

Ischemic hypoxic encephalopathy: The role of MRI of neonatal injury and medico-legal implication

2021

Hypoxic ischemic encephalopathy is one of the major causes of neonatal death and neurological disability in the child, and represents the most common birth injury claim. Intrapartum asphyxia often leads to several long-term sequalae, such as cerebral palsy and/or developmental delay, epilepsy. Through the neuroimaging it's possible to identify and define the different lesioned pictures and provide useful elements to establish the moment in which the damage occurred; indeed, timing of injury is a key element in the legal arena. Magnetic resonance imaging (MRI) is emerging as one of the most important tools in identifying the etiologic of neonatal encephalopathy as well as in predicting long-…

Malemedicine.medical_specialtyNeuroimagingHypoxic Ischemic EncephalopathyPathology and Forensic MedicineCerebral palsyMedico-legalEpilepsySettore MED/38 - Pediatria Generale E SpecialisticaNeuroimagingSettore MED/43 - Medicina LegaleMalpractice litigationMalpracticemedicineHumansIschemic Hypoxic encephalopathyIntensive care medicineAsphyxia Neonatorummedicine.diagnostic_testNeonatal encephalopathybusiness.industryInfant NewbornInfantMagnetic resonance imagingForensic Medicinemedicine.diseaseMagnetic Resonance ImagingBirth injurySettore MED/39 - Neuropsichiatria InfantileItalyMRI brainHypoxia-Ischemia BrainCerebral palsyFemalebusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaLawHuman
researchProduct

Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects

2007

Dopaminergic drugs and deep brain stimulation restore cortical inhibition in Parkinson disease (PD) patients. High-frequency rTMS was also found to increase cortical inhibition in PD but its therapeutic effect is still controversial. Here we hypothesize that, if dopaminergic drugs reverse to normal cortical excitability in M1, the effect of high-frequency (hf)-rTMS in PD patients could depend on whether they are in a medicated or unmedicated state. The present study aims to explore the lasting effects of sub-threshold hf rTMS trains over M1 on cortical inhibition in patients with "on" and without "off" L-DOPA treatment. Fourteen PD patients were examined twice while "on" and "off" medicatio…

Malemedicine.medical_specialtyNeurologyDeep brain stimulationCORTICAL SILENT PERIODmedicine.medical_treatmentStimulationMotor ActivityInhibitory postsynaptic potentialPAIRED-PULSE INHIBITIONAntiparkinson AgentsLevodopaDegenerative diseaseEVOKED-POTENTIALSmedicineHumansCORTEX EXCITABILITYAgedAged 80 and overSUBTHALAMIC NUCLEUSPARKINSONS-DISEASE PATIENTSGeneral NeuroscienceDopaminergicMotor CortexNeural InhibitionParkinson DiseaseMiddle Agedmedicine.diseaseFACILITATIONCombined Modality TherapyTranscranial Magnetic StimulationTranscranial magnetic stimulationBRAIN-STIMULATIONmedicine.anatomical_structureSettore MED/26 - NeurologiaFemaleREPETITIVE TMSPsychologyNeuroscienceMotor cortexExperimental Brain Research
researchProduct

The test accuracy of the Montreal Cognitive Assessment (MoCA) by stroke lateralisation

2017

Abstract Background The Montreal Cognitive Assessment (MoCA) is an increasingly popular screening tool for detecting cognitive impairment post-stroke. However its' test accuracy by stroke lateralisation is as yet unknown. Aim Our aim was to investigate whether the test accuracy of the MoCA differs by stroke lateralisation across different cognitive domains. Methods We retrospectively examined the cognitive profiles of 228 subacute stroke patients (86 Left, 142 Right), comparing MoCA-total and domain-specific scores with performance on detailed neuropsychological assessment. Results The prevalence of cognitive impairment detected on neuropsychological assessment was high and relatively compa…

Malemedicine.medical_specialtyNeuropsychological TestsAudiologySensitivity and SpecificityFunctional LateralityLateralization of brain functionExecutive Function03 medical and health sciencesCognition0302 clinical medicineBorderline intellectual functioningPrevalencemedicineHumansCognitive Dysfunction030212 general & internal medicineNeuropsychological assessmentPsychiatryStrokeAgedRetrospective Studiesmedicine.diagnostic_testNeuropsychologyMontreal Cognitive AssessmentCognitionMiddle Agedmedicine.diseaseExecutive functionsStrokeNeurologyFemaleNeurology (clinical)Psychology030217 neurology & neurosurgeryJournal of the Neurological Sciences
researchProduct

Epilepsy surgery in children with developmental tumours

2011

AbstractWe report our experience regarding evaluation, surgical treatment and outcomes in a population of 21 children with histopathologically confirmed developmental tumours [nine dysembryoplastic neuroepithelial tumours (DNET), ten gangliogliomas (GG) and two gangliocytomas (GC)] and related epilepsy, analyzing video-EEG, MRI and neuropsychological data, before and after surgery.Most children had focal epilepsy correlating well with lesion location. One patient had epileptic spasms and generalized discharges. Tumours were located in the temporal lobe in 13 patients. Mean age at surgery was 11.16 years. Postsurgical MRI showed residual tumour growth in one DNET. One child had a recurrent g…

Malemedicine.medical_specialtyPediatricsAdolescentPopulationClinical NeurologySeizure outcomeVideo-EEGLow-grade brain tumourGangliogliomaTemporal lobeYoung AdultEpilepsyEpilepsy surgerymedicineHumansEpilepsy surgeryChildeducationNeuropsychological outcomeGangliogliomaRetrospective StudiesDNETeducation.field_of_studyEpilepsybusiness.industryTumour-associated epilepsyInfantGanglioneuromaRetrospective cohort studyGeneral Medicinemedicine.diseaseNeoplasms NeuroepithelialSurgeryEpileptic spasmsNeurologyChild PreschoolFemaleNeurology (clinical)businessFollow-Up StudiesSeizure
researchProduct